Safety notice regarding some NovoPen 5s and NovoPen Echos
ABCD has received notification from NovoNordisk of an urgent Field Safety notice regarding some NovoPen 5s and NovoPen Echos - please see HERE for more information. Please inform your teams.
ABCD has received notification from NovoNordisk of an urgent Field Safety notice regarding some NovoPen 5s and NovoPen Echos - please see HERE for more information. Please inform your teams.
The ABCD-RA clinical practice guidelines on lipid management in adults with diabetes and nephropathy and/or CKD were published at the end of June: a summary of the guidance is in the British Journal of Diabetes (http://www.bjd-abcd.com/index.php/bjd/article/view/260/396 ) and the full guidelines can be downloaded from the websites of ABCD (click here) and the Renal A
The NHS Rightcare Diabetes Pathway setting out the expected standards of care for diabetes services has been published. This is essential reading for providers and commissioners alike.
Click HERE to download your copy. It will help members in their discussions with local commissioners and in preparations for the Getting it Right First Time visits later in the year.
I handed over the reins to Dinesh Nagi at a very enjoyable and successful ABCD meeting at the Titanic Centre in Belfast. Thank you to Russell Drummond and John Lindsay for the excellent programme. Patrick Bell's welcome address was both amusing and thought-provoking on a theme of reconciliation. He confessed to never having joined ABCD, but declared he would do so if he were starting his career today!
Executive Reshuffle.
ABCD is pleased to announce the launch of the ABCD nationwide IDegLira (Xultophy) audit and would like to invite you to take part.
The clinical trials of IDegLira seem to show in those uncontrolled on basal insulin (20-50units), IDegLira showed statistically improved HbA1c reductions in comparison to the up titration of insulin glargine U100 with fewer hypoglycamic episodes and less weight gain, and indeed with weight loss.
This year’s ABCD Clinical and Commissioning News – Live event on 6th July in London, Leeds, Bristol, and Manchester. This is of particular relevance to members practising in England.
Join us for a day of state-of-the-art updates following the ADA Scientific sessions, showcasing innovative practice and commissioning, and the chance to meet in locality groups with your commissioners.
ABCD has been asked to comment on three proposals set out in a letter from the DVLA describing the intention to amend the driving regulations for people with diabetes.
You can download the document HERE.
ABCD is pleased to announce the launch of the ABCD nationwide empagliflozin audit and would like to invite all ABCD members to take part.